ARCHIVES

As ImClone Investigation Continues, FDA Combines Drugs, Biologics Review; Memo Describes “Lengthy Process” That Led To FDA Decision; Oncology Community Praises FDA Move

This article is from The Cancer Letter archive.

Vol. 28 No. 33 | September 13, 2002

Download PDF Visit The Full Archive

Related Articles

Foundation Supports Chicago Researchers

September 10, 1993

NCI Advisors Approve $100M Set Aside for Physical Sciences-Oncology Centers.

December 12, 2008

DCT Board Okays 11 Concept Contract Recompetitions

October 26, 1984

Cancer Information Service facing $6 million cut, consolidation. Also Give NIH director greater authority, budget; review NCI’s special status, IOM says.

August 1, 2003

Reader Finds Letter insulting to Ethic Group

February 16, 1996

DeVita Era At NCI One Of New Programs, Remarkable Stability

August 19, 1988